Popović L, et al. Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies. Radiol Oncol. 2024;58(2):149-160.
Popović L, et al. Treatment sequencing in metastatic HR+/HER2− breast cancer: a Delphi consensus. Cancers (Basel). 2025;17(9):1412. doi:10.3390/cancers17091412.
Popović L, et al. Complementary therapies in early breast cancer: oncologists’ evidence-based decisions in a Southeast European vignette survey. Bosn J Basic Med Sci. 2026;26(7).
Cvetanović AS, Jankovic KB, Stojković AS, Živković ND, Kostić MS, Popović LS. Real-world clinical experience of first-line ribociclib combined with an aromatase inhibitor in metastatic breast cancer. Cancers (Basel). 2026;18(2):242. doi:10.3390/cancers18020242